IMS Health projects growth for Rx market
NORWALK, Conn. The global pharmaceutical market will reach a value of $880 billion next year, according to a report by market research firm IMS Health.
IMS Health forecasted 5% to 7% growth in 2011 in its annual IMS Market Prognosis, compared with 4% to 5% growth this year.
Generic drugs will become dominant in many therapies, as drugs with sales of more than $30 billion are expected to lose patent protection next year. These include Pfizer’s cholesterol-lowering drug Lipitor (atorvastatin calcium), Bristol-Myers Squibb’s and Sanofi-Aventis’ cardiovascular drug Plavix (clopidogrel bisulfate), Eli Lilly’s antipsychotic Zyprexa (olanzapine) and Johnson & Johnson’s antibiotic Levaquin (levofloxacin).
At the same time, much innovation is expected to occur in the area of specialty drugs –– drugs to treat such complex and often unmet therapeutic needs as multiple sclerosis, cancer and hepatitis C –– and patient access is expected to increase. IMS predicted five potential blockbuster drugs, meaning those with annual sales of $1 billion or more, will be approved over the course of the year.
Public and private payers are expected to reduce their growth in drug budgets, according to the report. In the United States, this is in the form of health plans increasing use of cost-sharing provisions and pre-authorizations.
“In 2011, we will see the loss of exclusivity for some iconic brands and a promising new wave of innovation,” IMS SVP Murray Aitken said. “It will also be a critical year for gauging how healthcare-reform initiatives in key markets evolve and play out amid the expected macroeconomic recovery. For pharmaceutical manufacturers, an unrelenting focus on bringing distinct value to patients and health systems will be essential to navigating this dynamic market.”
Overall, the company expected divergent growth in different markets. The United States will remain the largest drug market, growing 3% to 5% to $310 billion. Japan will grow by 5% to 7%, while Canada and the five major European markets of the United Kingdom, Germany, Spain, Italy and France will grow by 1% to 3%. The so-called “pharmerging markets” will experience the most dramatic growth, 15% to 17%, including 25% to 27% growth in China, which will remain the world’s third-largest pharmaceutical market at $50 billion.
NCPA to CMS: Medicaid reimbursements should adhere to healthcare-reform law provisions
ALEXANDRIA, Va. The National Community Pharmacists Association is urging the Centers for Medicare and Medicaid Services to follow guidance that Congress included in the healthcare-reform law in its implementation of a new Medicaid generic drug reimbursement formula based on average manufacturer price, the organization said Tuesday.
CMS recently withdrew provisions that would have dramatically cut Medicaid pharmacy reimbursement to community pharmacies from a previously proposed AMP rule due to an injunction that the NCPA obtained in 2007.
In a letter to Congress, the NCPA recommended giving manufacturers more direction in calculating their AMPs, such as requiring them to only include prices paid by wholesalers for drugs subsequently sold at pharmacies; recognizing the ill effect that the NCPA said curtailed generic drug reimbursements would have on retail pharmacies; and setting up a process by which revised federal upper limits resulting from the revised AMP data will be implemented in order to minimize disruption for patients and pharmacies.
“In many ways, independent community pharmacies are the backbone of Medicaid’s prescription drug benefit,” NCPA acting EVP and CEO Douglas Hoey said. “Pharmacies will become an even more important source of health care-related services for Medicaid beneficiaries as new healthcare reform provisions are implemented.”
Internet is go-to for health-and-wellness information, study shows
NEW YORK The types of websites consumers turn to for health-and-wellness information and the reasons they go online for such information are greatly influenced by the stage of the condition they are experiencing and varies by ailment type, age and gender, according to research released Wednesday by Kantar Media.
“The Internet has become the source people turn to for health information,” stated Jayne Krahn, VP consumer health and custom research for Kantar Media. “While much is known about website visitation and patterns, less is known about the why and when, in terms of ailment conditions and stages,” she said. “This in-depth information … can help marketers and content creators better plan, position and develop creative. It also has relevance for magazine publishers looking to demonstrate how their digital offerings can provide unique reach and build frequency for advertisers.”
While health-information websites were used more often than search engines across all stages of the 40 ailments covered in the study, search engines were the preferred next option at early stages of a condition. However, for those recently diagnosed, in recovery or living with an ongoing condition, websites dedicated to a particular condition were preferred over search engines.
Online behavior also is defined by type of ailment when it comes to those sites best able to drive visitors back. For example, the study found that those who used the Internet for diabetes information were twice as likely to go back to websites that offered helpful tools or connected them to a larger community of people with the same condition. Sites that offer easy access to medical professionals are favored by those researching cardiovascular or respiratory conditions.
Findings also indicated that men and women use online health research differently. Nearly 84% of women researched for someone else, compared with 75% of men who researched for others. When it comes to reading reviews or ratings about doctors, however, men were just as likely to do so as women.
With regard to age, 18 to 34 year olds were more likely to go online to find healthcare professionals and read reviews or ratings about physicians, while those older than 50 years sought information about a condition or treatment after visiting a doctor.
The analysis comes out of the MARS 2010 Online Behavior Study. The study, conducted among more than 5,000 respondents in the second quarter of this year, is an extension of the 2010 MARS OTC/DTC Study.
Among other findings:
- Of the 178 million Americans who have gone online in the past month, more than 89% have used the Internet for health research, with the typical user being female and younger than 50 years of age;
- The primary reason for going online for health information was to gain general knowledge about a condition (71%), followed by researching symptoms that either the individual or someone else was experiencing (59%);
- 56% of respondents said a healthcare professional recommendation makes a health website trustworthy, followed by 46% who said the inclusion of academic articles or scientific research does, and 39% who said having information that is easy to understand does;
- 79% said that they felt the Internet provides a wealth of resources when they are searching for health-and-wellness information, while 74% said they were very cautious about which websites they accessed for health-and-wellness information; and
- For those recently diagnosed with a condition, 77% said they first turned to online sources for information, second only to 81% who said they turned to a healthcare professional. Nearly 51% relied on magazines, pamphlets or other print publications.